← Back to Search

Behavioral Intervention

TASC Intervention for Asthma (TASC Trial)

Led By Rachelle R Ramsey, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient age between 12-18 years
Patient is diagnosed with severe-persistent or moderate-persistent asthma per NAEPP asthma guidelines
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

TASC Trial Summary

This trial is testing a new intervention to help people with asthma better follow their treatment plan.

Who is the study for?
This trial is for adolescents aged 12-18 with moderate to severe persistent asthma, as defined by NAEPP guidelines. They must be on daily inhaled medication and fluent in English. It's not suitable for those with developmental disorders, other chronic diseases besides asthma or allergic disease, serious mental illness, cognitive deficits, or who receive school-administered daily controller medication.Check my eligibility
What is being tested?
The study is examining the effectiveness of a Technology-Assisted Stepped Care (TASC) intervention aimed at improving medication adherence among teenagers with asthma. Participants will either receive this new TASC intervention or continue with their usual treatment plan.See study design
What are the potential side effects?
Since the TASC intervention involves technology-assisted care rather than medications, traditional side effects are not expected. However, there may be indirect effects related to changes in treatment adherence that could affect asthma control.

TASC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 12 and 18 years old.
My asthma is diagnosed as severe or moderate persistent.
I use daily asthma medication, including inhaled steroids and a long-acting bronchodilator.

TASC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inhaler Adherence Electronic Monitoring
Secondary outcome measures
Asthma Control Test (ACT)
Asthma Severity Score via TreatSmart
Attendance/Participation rates
+13 more
Other outcome measures
Adolescent Medication Barriers Scale (AMBS)
Asthma Responsibility Questionnaire (ARQ)
Behavioral Assessment (BASC-3)
+7 more

TASC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TASC InterventionExperimental Treatment1 Intervention
Step 1 of the intervention includes educational materials related to asthma. Step 2 includes electronic monitoring of adherence and a text messaging intervention personally tailored to the participant. Step 3 includes problem solving telehealth sessions with a trained clinician.
Group II: Treatment as UsualActive Control1 Intervention
Participants will not receive any intervention.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,521 Total Patients Enrolled
16 Trials studying Asthma
2,816 Patients Enrolled for Asthma
Rachelle R Ramsey, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

TASC Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04365556 — N/A
Asthma Research Study Groups: TASC Intervention, Treatment as Usual
Asthma Clinical Trial 2023: TASC Intervention Highlights & Side Effects. Trial Name: NCT04365556 — N/A
TASC Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04365556 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial enrolling patients who are under the age of 60?

"In order to qualify for this trial, patients must be young adults aged 12 to 18. Out of the total number of clinical trials taking place, 117 are for people under the age of 18 and 202 are for elderly patients."

Answered by AI

How many people are currently involved in this clinical trial?

"That is correct. The trial, which has been updated as recently as June 22nd 2021, is looking for 70 individuals to participate at 1 site."

Answered by AI

What are some of the risks associated with TASC Intervention?

"While there is some data suggesting that TASC Intervention is safe, it only received a score of 2 because there is no evidence yet to support its efficacy."

Answered by AI

Is this research opportunity still available to potential participants?

"From what is published on clinicaltrials.gov, it appears that this study requires more patients and is actively seeking them. The trial was first announced on November 19th, 2019 with the most recent update being from June 22nd, 2021."

Answered by AI

Are there specific inclusion criteria for patients who want to participate in this trial?

"The aim of this study is to recruit 70 adolescents aged 12-18 that suffer from asthma. To be eligible, patients must meet the following requirements: A diagnosis of severe-persistent or moderate-persistent asthma according to NAEPP guidelines, A daily prescription of an inhaled controller medication or a combination of an inhaled corticosteroid and long-acting beta agonist as well as a beta agonist bronchodilator English fluency for patient, caregiver, and clinician."

Answered by AI

Who else is applying?

What site did they apply to?
Cincinnati Children's Medical Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~15 spots leftby Jul 2025